[1] 中国抗癌协会肝癌专业委员会, 中国抗癌协会临床肿瘤学协作专业委员会, 中华医学会肝病学分会肝癌学组. 肝癌局部消融治疗规范的专家共识. 肿瘤, 2011, 31(5): 385-388.
[2] Waitz R, Solomon SB. Can local radiofrequency ablation of tumors generate systemic immunity against metastatic disease? Radiology, 2009, 251(1): 1-2.
[3] Haen SP, Pereira PL, Salih HR, et al. More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol, 2011, 2011:160250.
[4] Goldberg SN. Science to practice: can we expand focal interventional oncologic ablation treatments into an effective systemic therapy?. Radiology, 2013,267(2):321-323.
[5] Gravante G, Ong SL, Metcalfe MS, et al. The effects of radiofrequency ablation on the hepatic parenchyma: histological bases for tumor recurrences. Surg Oncol, 2011,20(4):237-245.
[6] Gravante G, Sconocchia G, Ong SL, et al. Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies. Liver Int, 2009,29(1):18-24.
[7] Fietta AM, Morosini M, Passadore I, et al. Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer. Hum Immunol, 2009, 70(7):477-486.
[8] Haen SP, Gouttefangeas C, Schmidt D, et al. Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation. Cell Stress Chaperones, 2011,16(5):495-504.
[9] Zerbini A, Pilli M, Fagnoni F, et al. Increased immunostimulatory activity conferred to antigenpresenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation. J Immunother, 2008, 31(3):271-282.
[10] Dromi SA, Walsh MP, Herby S, et al. Radiofrequency ablation induces antigenpresenting cell infiltration and amplification of weak tumorinduced immunity. Radiology, 2009,251(1):58-66.
[11] Wissniowski TT, Hansler J, Neureiter D, et al. Activation of tumorspecific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res, 2003,63(19):6496-6500.
[12] Hansler J, Wissniowski TT, Schuppan D, et al. Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radiofrequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases. World J Gastroenterol, 2006,12(23): 3716-3721.
[13] Ali MY, Grimm CF, Ritter M, et al. Activation of dendritic cells by local ablation of hepatocellular carcinoma. J Hepatol, 2005, 43(5):817-822.
[14] Zerbini A, Pilli M, Penna A, et al. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor specific T-cell responses. Cancer Res, 2006, 66(2):1139-1146.
[15] Nobuoka D, Motomura Y, Shirakawa H, et al. Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytes. Int J Oncol, 2012, 40(1):63-70.
[16] Napoletano C, Taurino F, Biffoni M, et al. RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients. Int J Oncol, 2008, 32(2):481-490.
[17] 崇杨, 江涛, 张东华,等. 射频消融术对原发性肝癌患者甲胎蛋白和外周血CD4+CD25+Foxp3+Treg细胞的影响. 江苏大学学报(医学版), 2013,23(2): 177-179.
[18] Liu Q, Zhai B, Yang W, et al. Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine. Mol Ther, 2009, 17(12):2049-2057.
[19] Johnson EE, Yamane BH, Buhtoiarov IN, et al. Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma. Clin Cancer Res, 2009, 15(15):4875-4884.
[20] SanchezOrtiz RF, Tannir N, Ahrar K, et al. Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine?. J Urol, 2003, 170(1): 178-179.
[21] Ma H, Zhang Y, Wang Q, et al. Therapeutic safety and effects of adjuvant autologous RetroNectin activated killer cell immunotherapy for patients with primary hepatocellular carcinoma after radiofrequency ablation. Cancer Biol Ther, 2010, 9(11):903-907.
[22] Kroeze SG, Daenen LG, Nijkamp MW, et al. Radio frequency ablation combined with interleukin-2 induces an antitumor immune response to renal cell carcinoma in a murine model. J Urol, 2012, 188(2):607-614.
[23] Fagnoni FF, Zerbini A, Pelosi G, et al. Combination of radiofrequency ablation and immunotherapy. Front Biosci, 2008, 13:369-381. |